Pyxis Oncology Company

Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer.
Industry: Gene therapy
Headquarters: Boston, Massachusetts, United States
Founded Date: 2019-01-01
Employees Number: 11-50
Funding Status: IPO
Investors Number: 21
Total Funding: 174000000
Last Funding Date: 2021
Last Funding Type: Series B

Visit Website
info@pyxisoncology.com
Register and Claim Ownership